High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study

Journal of Clinical Oncology

Volumn 12, Issue 6, 1994, Pages 1223-1231

  Siegert, Wolfgang ^a   Beyer, Jörg ^b   Strohscheer, Imke ^b   Baurmann, Herrad ^b   Oettle, Helmut ^b   Zingsem, Jürgen ^b   Zimmermann, Robert ^b   Bokemeyer, Carsten ^b   Schmoll, Hans Joachim ^b   Huhn, Dieter ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELL TRANSPLANTATION; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; GERM CELL TUMOR; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; STEM CELL;

EID: 0028229053     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.6.1223     Document Type: Article

References (28)

1. Williams S, Birch R, Einhorn LH, et al: Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
2. Harstrick A, Schmoll H-J, Wilke H, et al: Cisplatin, etoposide and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 9:1549-1555, 1991
3. Loehrer PJ, Einhorn LH, Williams SD: VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4:528-536, 1986
4. Bosl GJ, Yagoda A, Golbey RB, et al: Role of etoposide-based chemotherapy with refractory or relapsed germ cell tumors. Am J Med 78:423-438, 1985
5. Motzer RJ, Cooper K, Geller NL, et al: The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66:2476-2481, 1990
6. Harstrick A, Schmoll H-J: The dose response relationship as the basis for high-dose chemotherapy - Experimental and preclinical data. Bone Marrow Transplant 10:8, 1992 (suppl 2)
7. Ozols RF, Ihde DC, Linehan M, et al: A randomized trial of standard chemotherapy versus a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ cell tumors. J Clin Oncol 6:1031-1040, 1988
8. Samson MK, Rivkin SE, Jones SE, et al: Dose-response and dose-survival advantage for high versus low dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study. Cancer 53:1029-1035, 1984
9. Nichols CR, Williams SD, Loehrer PJ, et al: Randomized study of cisplatin dose intensity in advanced germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 9:1163-1172, 1991
10. Nichols CR, Tricot G, Williams SD, et al: Dose-intensive chemotherapy in refractory germ cell cancer - A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939, 1989
11. Birch R, Williams S, Cone A, et al: Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4:400-407, 1986
12. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Nichols CR, Andersen J, Lazarus HM, et al: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol. J Clin Oncol 10:558-563, 1992
14. Broun ER, Nichols CR, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117:124-128, 1992
15. Linkesch W, Krainer M, Wagner A: Phase I/II trial of ultra-high carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed non-seminomatous germ cell tumors. Bone Marrow Transplant 10:28-29, 1992 (suppl 2)
16. Droz JP, Pico JL, Ghosn M, et al: Long-term survivors after salvage high-dose chemotherapy with bone marrow rescue in refractory germ cell cancer. Eur J Cancer 27:831-835, 1991
17. Motzer RJ, Gulati S, Crown JP, et al: High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Cancer 69:550-556, 1992
18. Mulder PO, DeVries EGE, Koops HS, et al: Chemotherapy with maximally tolerable doses of VP-16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors. Eur J Cancer Clin Oncol 24:675-679, 1988
19. Wheeler BM, Loehrer P, Williams SD, et al: Ifosfamide in refractory male germ cell tumors. J Clin Oncol 4:28-34, 1986
20. Wolff SN, Johnson DH, Hainsworth JD, et al: High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase II study. J Clin Oncol 2:271-274, 1984
21. Goren MP, Wright RK, Pratt CB, et al: Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephroloxicity by prior cis-diamminedichloroplatinum(II) therapy. Cancer Res 47:1457-1460, 1987
22. Broun ER, Nichols CR, Tricot G, et al: High dose carboplatin/ VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors. Bone Marrow Transplant 7:53-56, 1991
23. Cerny T, Castiglione M, Brunner K, et al: Ifosfamide by continuous infusion to prevent encephalopathy. Lancet 335:175, 1990
24. Shea TC, Flaherty M, Elias A, et al: A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol 7:651-661, 1989
25. Mandanas RA, Broun ER, Nichols CR, et al: Phase I/II dose escalation study of carboplatin (CBDCA) and etoposide (VP-16) with autologous marrow support done in tandem for refractory germ cell tumors. Proc Am Soc Clin Oncol 12:240, 1993 (abstr)
26. Rosti G, Albertazzi L, Salvioni R, et al: High-dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: A phase two study. Ann Oncol 3:809-812, 1992
27. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomas. N Engl J Med 316:1493-1498, 1987
28. Broun ER, Nichols CR, Einhorn LH, et al: Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary mediastinal germ cell tumors. Cancer 68:1513-1515, 1991